Protoporphyrin IX-Dependent Antiviral Effects of 5-Aminolevulinic Acid against Feline Coronavirus Type II
Viruses · 2024
DOI: 10.3390/v16101595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Tomoyoshi Doki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Infectious Disease, School of Veterinary Medicine, Kitasato University, Towada 034-8628, Aomori, Japan. Hauptthemen laut MEDLINE: Aminolevulinic Acid, Protoporphyrins, Antiviral Agents, Coronavirus, Feline. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KIYAN PHARMA Co., Ltd. (formerly Neopharma Japan Co., Ltd.), Japan Society for the Promotion of Science (JSPS), JSPS KAKENHI.
Abstract (Originalsprache)
5-Aminolevulinic acid (5-ALA), a non-proteinogenic amino acid, is an intermediate in the biosynthesis of heme and exerts antiviral effects against feline coronavirus (FCoV); however, the underlying mechanisms remain unclear. In the biosynthesis of heme, 5-ALA is condensed and converted to protoporphyrin IX (PpIX), which is then transformed into heme by the insertion of ferrous iron. Previous research has suggested that the metabolites generated during heme biosynthesis contribute to the antiviral effects of 5-ALA. Therefore, the present study investigated the in vitro mechanisms responsible for the antiviral effects of 5-ALA. The results obtained revealed that 5-ALA and PpIX both effectively reduced the viral titer in the supernatant of FCoV-infected fcwf-4 cells. Moreover, PpIX exerted virucidal effects against FCoV. We also confirmed that 5-ALA increased PpIX levels in cells. While hemin induced heme oxygenase-1 gene expression, it did not reduce the viral titer in the supernatant. Sodium ferrous citrate decreased PpIX levels and suppressed the antiviral effects of 5-ALA. Collectively, these results suggest that the antiviral effects of 5-ALA against FCoV are dependent on PpIX.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Veterinary Infectious Disease, School of Veterinary Medicine, Kitasato University, Towada 034-8628, Aomori, Japan.
- Laboratory of Veterinary Biochemistry, School of Veterinary Medicine, Kitasato University, Towada 034-8628, Aomori, Japan.
ORCID-Profile: Tomoyoshi Doki, Tomomi Takano
Förderung
- KIYAN PHARMA Co., Ltd. (formerly Neopharma Japan Co., Ltd.)
- Japan Society for the Promotion of Science (JSPS)
- JSPS KAKENHI
Zitieren
APA
Doki, T., Shimada, J., Tokunaga, M., To, K., Orino, K., & Takano, T. (2024). Protoporphyrin IX-Dependent Antiviral Effects of 5-Aminolevulinic Acid against Feline Coronavirus Type II. Viruses. https://doi.org/10.3390/v16101595
Vancouver
Doki T, Shimada J, Tokunaga M, To K, Orino K, Takano T. Protoporphyrin IX-Dependent Antiviral Effects of 5-Aminolevulinic Acid against Feline Coronavirus Type II. Viruses. 2024. doi:10.3390/v16101595
BibTeX
@article{Doki2024,
author = {Doki, Tomoyoshi and Shimada, Junna and Tokunaga, Misa and To, Kaito and Orino, Koichi and Takano, Tomomi},
title = {Protoporphyrin IX-Dependent Antiviral Effects of 5-Aminolevulinic Acid against Feline Coronavirus Type II},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16101595}
}
EUVIMED